RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | 8.97% | 117.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.97% | 117.76% | |||
| Cost of Revenue | -65.89% | 268.64% | |||
| Gross Profit | 438.58% | -117.15% | |||
| SG&A Expenses | 41.65% | -28.12% | |||
| Depreciation & Amortization | 67.60% | -37.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.54% | 13.52% | |||
| Operating Income | -16.05% | -0.51% | |||
| Income Before Tax | 2.23% | -0.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.23% | -0.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.23% | -0.33% | |||
| EBIT | -16.05% | -0.51% | |||
| EBITDA | -3.23% | -18.51% | |||
| EPS Basic | 5.74% | 1.42% | |||
| Normalized Basic EPS | -11.45% | 1.50% | |||
| EPS Diluted | 5.74% | 1.42% | |||
| Normalized Diluted EPS | -11.45% | 1.50% | |||
| Average Basic Shares Outstanding | 3.96% | 1.98% | |||
| Average Diluted Shares Outstanding | 3.96% | 1.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
